Immunoregulation—Innate Immune Responses

 Tuesday, May 10, 2022     8:00 AM – 10:00 AM ET     Room B110–112

Immunoregulation—Innate Immune Responses

Chairs

• Meera Nair, Univ. of California, Riverside
• Emily Howard, Univ. of Southern California

Speakers

• Mandy I. Cheng, Univ. of California, Los Angeles, UTX is an epigenetic regulator of natural killer cell development and anti-viral effector function.
• Ajay Kumar, Univ. of Michigan, Glutamine addiction in NKT cells is regulated by AMPK-mTORC1 axis
• Zarina Brune, Feinstein Inst. for Med. Res., Northwell Hlth., IRF5 regulation of CD4+ T cell metabolism controls CD40L expression
• Erin E. West, NHLBI, NIH, Setting the pace: CD4 T cell-intrinsic Arginase 1 orchestrates Th1 induction and contraction
• Jing Li, Stanford Univ. Sch. of Med., Human KIR⁺CD8⁺ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19
• Peyman Ghorbani, Univ. of Ottawa, Choline metabolism underpins macrophage IL-4 polarization in vitro and in vivo
• Mandy M. Chan, Washington Univ. in St Louis Sch. of Med., Enhancing lysosomal lipid metabolism prevents the loss of Kupffer cells in non-alcoholic steatohepatitis and attenuates liver pathology